{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:46:18Z","timestamp":1789825578378,"version":"4.0.1"},"reference-count":184,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["ISRM\/12\/(127)\/2020"],"award-info":[{"award-number":["ISRM\/12\/(127)\/2020"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.arr.2024.102342","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T07:47:59Z","timestamp":1715845679000},"page":"102342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Navigating the Maze of Alzheimer\u2019s disease by exploring BACE1: Discovery, current scenario, and future prospects"],"prefix":"10.1016","volume":"98","author":[{"given":"Faiza","family":"Iram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaoud","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghulam Md","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Imtaiyaz","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9060-7970","authenticated-orcid":false,"given":"Asimul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2024.102342_bib1","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3390\/polym13071051","article-title":"Potential role of nanoparticles in treating the accumulation of amyloid-beta peptide in Alzheimer\u2019s patients","volume":"13","author":"Abbas","year":"2021","journal-title":"Polymers"},{"key":"10.1016\/j.arr.2024.102342_bib2","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2174\/1570159X20666211231090659","article-title":"Stem cell-based therapeutic and diagnostic approaches in Alzheimer's disease","volume":"20","author":"Abdi","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.arr.2024.102342_bib3","first-page":"1","article-title":"Identifying \u03b2-secretase 1 (BACE1) inhibitors from plant-based compounds: an approach targeting Alzheimer\u2019s therapeutics employing molecular docking and dynamics simulation","author":"Alrouji","year":"2023","journal-title":"Mol. Divers."},{"key":"10.1016\/j.arr.2024.102342_bib4","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0306-4522(00)00516-9","article-title":"Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization","volume":"102","author":"Arendt","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.arr.2024.102342_bib5","doi-asserted-by":"crossref","first-page":"8823","DOI":"10.3390\/molecules27248823","article-title":"BACE1 Inhibitors for Alzheimer\u2019s Disease: The Past, Present and Any Future?","volume":"27","author":"Bazzari","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2024.102342_bib6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/molecules27010236","article-title":"New promising therapeutic avenues of curcumin in brain diseases","volume":"27","author":"Benameur","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2024.102342_bib7","doi-asserted-by":"crossref","first-page":"10879","DOI":"10.1074\/jbc.M009899200","article-title":"Post-translational processing of \u03b2-secretase (\u03b2-amyloid-converting enzyme) and its ectodomain shedding: the pro-and transmembrane\/cytosolic domains affect its cellular activity and amyloid-\u03b2 production","volume":"276","author":"Benjannet","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102342_bib8","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.drudis.2020.05.001","article-title":"Role of oxidative stress in depression","volume":"25","author":"Bhatt","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.arr.2024.102342_bib9","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.drudis.2020.12.004","article-title":"Role of reactive oxygen species in the progression of Alzheimer\u2019s disease","volume":"26","author":"Bhatt","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.arr.2024.102342_bib10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3233\/JAD-2011-111013","article-title":"Infant exposure to lead (Pb) and epigenetic modifications in the aging primate brain: implications for Alzheimer's disease","volume":"27","author":"Bihaqi","year":"2011","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.arr.2024.102342_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1184006","article-title":"Design, in silico and pharmacological evaluation of a peptide inhibitor of BACE-1","volume":"14","author":"Boldin","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.arr.2024.102342_bib12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fnagi.2018.00118","article-title":"The physiological roles of amyloid-\u03b2 peptide hint at new ways to treat Alzheimer's disease","volume":"10","author":"Brothers","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2024.102342_bib13","first-page":"1163","article-title":"Mutations in presenilin 2 and its implications in Alzheimer\u2019s disease and other dementia-associated disorders.","author":"Cai","year":"2015","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.arr.2024.102342_bib14","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1021\/cn500148z","article-title":"The role of tau oligomers in the onset of Alzheimer's disease neuropathology","volume":"5","author":"C\u00e1rdenas-Aguayo","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2024.102342_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200344","article-title":"BACE1-cleavage of Sez6 and Sez6L is elevated in Niemann-Pick type C disease mouse brains","volume":"13","author":"Causevic","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.arr.2024.102342_bib16","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3233\/JAD-160701","article-title":"AZD3293: Pharmacokinetic and pharmacodynamic effects in healthy subjects and patients with Alzheimer\u2019s disease","volume":"55","author":"Cebers","year":"2017","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.arr.2024.102342_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-018-0383-x","article-title":"Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer\u2019s disease.","volume":"10","author":"Chatterjee","year":"2018","journal-title":"Alzheimer'S. Res. Ther."},{"key":"10.1016\/j.arr.2024.102342_bib18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s12640-023-00634-7","article-title":"Challenges and opportunities of metal chelation therapy in trace metals overload-induced Alzheimer\u2019s disease","volume":"41","author":"Chaudhari","year":"2023","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.arr.2024.102342_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2023.137265","article-title":"TNIP2 inhibits amyloidogenesis by regulating the 3\u2032 UTR of BACE1: An in vitro study.","volume":"808","author":"Chen","year":"2023","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2024.102342_bib20","article-title":"Periodontitis salivary microbiota aggravates ischemic stroke through IL-17A","volume":"16","author":"Chen","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2024.102342_bib21","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.3390\/ph15121560","article-title":"Current Pharmacotherapy and Multi-Target Approaches for Alzheimer\u2019s Disease","volume":"15","author":"Cheong","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.arr.2024.102342_bib22","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s10571-017-0574-1","article-title":"Tau proteins and tauopathies in Alzheimer\u2019s disease","volume":"38","author":"Chong","year":"2018","journal-title":"Cell. Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.arr.2024.102342_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1750-1326-2-22","article-title":"The Alzheimer's disease \u03b2-secretase enzyme, BACE1","volume":"2","author":"Cole","year":"2007","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2024.102342_bib24","doi-asserted-by":"crossref","DOI":"10.2217\/nmt-2019-0034","article-title":"Alzheimer\u2019s disease: the potential of epigenetic treatments and current clinical candidates","author":"Coneys","year":"2020","journal-title":"Neurodegener. Dis. Manag. 10, 543-558"},{"key":"10.1016\/j.arr.2024.102342_bib25","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1074\/jbc.M006947200","article-title":"Processing of \u03b2-secretase by furin and other members of the proprotein convertase family","volume":"276","author":"Creemers","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102342_bib26","article-title":"Alzheimer's disease drug development pipeline: 2020","volume":"6","author":"Cummings","year":"2020","journal-title":"Alzheimer'S. Dement.: Transl. Res. Clin. Interv."},{"key":"10.1016\/j.arr.2024.102342_bib27","article-title":"Alzheimer's disease drug development pipeline: 2021","volume":"7","author":"Cummings","year":"2021","journal-title":"Alzheimer'S. Dement.: Transl. Res. Clin. Interv."},{"key":"10.1016\/j.arr.2024.102342_bib28","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.2147\/IJN.S305851","article-title":"Improving drug delivery for Alzheimer\u2019s disease through nose-to-brain delivery using nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ hydrogels","author":"Cunha","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.arr.2024.102342_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113576","article-title":"Anti-Alzheimer's disease potential of traditional chinese medicinal herbs as inhibitors of BACE1 and AChE enzymes","volume":"154","author":"Dai","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.arr.2024.102342_bib30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s40263-019-00613-7","article-title":"A close look at BACE1 inhibitors for Alzheimer\u2019s disease treatment.","volume":"33","author":"Das","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.arr.2024.102342_bib31","first-page":"52","article-title":"Fragment-based designing for the generation of novel leads against BACE1","volume":"15","author":"Das","year":"2015","journal-title":"Cent. Nerv. Syst. Agents Med. Chem. (Former. Curr. Med. Chem. -Cent. Nerv. Syst. Agents)"},{"issue":"1","key":"10.1016\/j.arr.2024.102342_bib32","article-title":"Common Signaling Pathways Involved in Alzheimer\u2019s Disease and Stroke: Two Faces of the Same Coin","volume":"18","author":"Das","year":"2023","journal-title":"J. Alzheimer'S. Dis. Rep."},{"key":"10.1016\/j.arr.2024.102342_bib33","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/hep.31403","article-title":"Biopsy pathology and immunohistochemistry of a case of immune-mediated drug-induced liver injury with Atabecestat","volume":"73","author":"De Jonghe","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.arr.2024.102342_bib34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2024.102342_bib35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fphys.2012.00008","article-title":"The membrane-bound aspartyl protease BACE1: molecular and functional properties in Alzheimer\u2019s disease and beyond","volume":"3","author":"Dislich","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.arr.2024.102342_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/srep34051","article-title":"Rescue of early bace-1 and global DNA demethylation by S-adenosylmethionine reduces amyloid pathology and improves cognition in an Alzheimer\u2019s model","volume":"6","author":"Do Carmo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102342_bib37","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2174\/156720508783954695","article-title":"Assembly, maturation, and trafficking of the \u03b3-secretase complex in Alzheimer's disease","volume":"5","author":"Dries","year":"2008","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.arr.2024.102342_bib38","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","article-title":"Randomized trial of verubecestat for mild-to-moderate Alzheimer\u2019s disease","volume":"378","author":"Egan","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2024.102342_bib39","series-title":"Major neurocognitive disorder (dementia), StatPearls [Internet]","author":"Emmady","year":"2022"},{"key":"10.1016\/j.arr.2024.102342_bib40","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s12640-021-00381-7","article-title":"Targeting common signaling pathways for the treatment of stroke and Alzheimer\u2019s: A comprehensive review","volume":"39","author":"Eskandari","year":"2021","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.arr.2024.102342_bib41","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13578-023-01000-y","article-title":"A novel rhein-huprine hybrid ameliorates disease-modifying properties in preclinical mice model of Alzheimer\u2019s disease exacerbated with high fat diet","volume":"13","author":"Espinosa-Jim\u00e9nez","year":"2023","journal-title":"Cell Biosci."},{"key":"10.1016\/j.arr.2024.102342_bib42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.cmet.2011.06.018","article-title":"Bace2 is a \u03b2 cell-enriched protease that regulates pancreatic \u03b2 cell function and mass","volume":"14","author":"Esterhazy","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.arr.2024.102342_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtemb.2021.126779","article-title":"Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer\u2019s disease: Limitations, and current and future perspectives","volume":"67","author":"Fasae","year":"2021","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.arr.2024.102342_bib44","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.0022-3042.2002.00806.x","article-title":"The disulphide bonds in the catalytic domain of BACE are critical but not essential for amyloid precursor protein processing activity","volume":"80","author":"Fischer","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2024.102342_bib45","doi-asserted-by":"crossref","first-page":"14979","DOI":"10.1073\/pnas.261463298","article-title":"The \u03b3-secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus","volume":"98","author":"Gao","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.arr.2024.102342_bib46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-1326-9-4","article-title":"BACE1 activity regulates cell surface contactin-2 levels","volume":"9","author":"Gautam","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2024.102342_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.117047","article-title":"Guanidine-based \u03b2 amyloid precursor protein cleavage enzyme 1 (BACE-1) inhibitors for the Alzheimer's disease (AD): A Review","author":"Gehlot","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.arr.2024.102342_bib48","doi-asserted-by":"crossref","first-page":"6765","DOI":"10.1039\/C3CS60460H","article-title":"BACE1 (\u03b2-secretase) inhibitors for the treatment of Alzheimer's disease","volume":"43","author":"Ghosh","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.arr.2024.102342_bib49","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1021\/ja000300g","article-title":"Design of potent inhibitors for human brain memapsin 2 (\u03b2-secretase)","volume":"122","author":"Ghosh","year":"2000","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.arr.2024.102342_bib50","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3233\/ADR-180089","article-title":"BACE1 translation: At the crossroads between Alzheimer\u2019s disease neurodegeneration and memory consolidation","volume":"3","author":"Guix","year":"2019","journal-title":"J. Alzheimer'S. Dis. Rep."},{"key":"10.1016\/j.arr.2024.102342_bib51","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/alz.12694","article-title":"Global estimates on the number of persons across the Alzheimer's disease continuum","volume":"19","author":"Gustavsson","year":"2023","journal-title":"Alzheimer'S. Dement."},{"key":"10.1016\/j.arr.2024.102342_bib52","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The amyloid-\u03b2 pathway in Alzheimer\u2019s disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2024.102342_bib53","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.biopsych.2020.02.001","article-title":"The \u03b2-secretase BACE1 in Alzheimer\u2019s disease","volume":"89","author":"Hampel","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.arr.2024.102342_bib54","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3389\/fnmol.2017.00189","article-title":"Amyloid-precursor like proteins aplp1 and aplp2 are dispensable for normal development of the neonatal respiratory network","volume":"10","author":"Han","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.arr.2024.102342_bib55","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"science"},{"key":"10.1016\/j.arr.2024.102342_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2018.06.041","article-title":"P1-040: ELENBECESTAT, A NOVEL BACE INHIBITOR, DEMONSTRATES SIMILAR PHARMACOKINETICS AND TOLERABILITY IN JAPANESE SUBJECTS WITH MULTIPLE DOSINGS.","volume":"14","author":"Hayata","year":"2018","journal-title":"Alzheimer'S. Dement."},{"key":"10.1016\/j.arr.2024.102342_bib57","doi-asserted-by":"crossref","first-page":"11696","DOI":"10.1074\/jbc.M411296200","article-title":"GGA proteins mediate the recycling pathway of memapsin 2 (BACE)","volume":"280","author":"He","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102342_bib58","doi-asserted-by":"crossref","first-page":"10963","DOI":"10.1021\/bi026232n","article-title":"Crystal structure of memapsin 2 (\u03b2-secretase) in complex with an inhibitor OM00-3","volume":"41","author":"Hong","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2024.102342_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1244159","article-title":"Sulindac sulfide as a non-immune suppressive \u03b3-secretase modulator to target triple-negative breast cancer","volume":"14","author":"Hossain","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.arr.2024.102342_bib60","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.celrep.2013.06.005","article-title":"BACE1 regulates hippocampal astrogenesis via the Jagged1-Notch pathway","volume":"4","author":"Hu","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.arr.2024.102342_bib61","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s12276-022-00754-8","article-title":"\u03b3-Secretase in Alzheimer\u2019s disease","volume":"54","author":"Hur","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.arr.2024.102342_bib62","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1471-4159.2006.04260.x","article-title":"Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases \u03b2-cleavage of amyloid precursor protein and amyloid-\u03b2 production in vivo","volume":"100","author":"Hussain","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2024.102342_bib63","article-title":"COGNITIVE OUTCOMES IN THE VERY MILD SUBGROUP IN THE PHASE 3 STUDIES OF ELENBECESTAT IN EARLY AD (MISSION AD PROGRAM)","volume":"2021","author":"Irizarry","year":"2021"},{"key":"10.1016\/j.arr.2024.102342_bib64","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuron.2018.06.003","article-title":"Dendritic tau in Alzheimer\u2019s disease","volume":"99","author":"Ittner","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2024.102342_bib65","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","article-title":"Plasma P-tau181 in Alzheimer\u2019s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer\u2019s dementia","volume":"26","author":"Janelidze","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2024.102342_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.291","article-title":"Application of stem cells in regeneration medicine","volume":"4","author":"Jin","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.arr.2024.102342_bib67","first-page":"94","article-title":"Oxidative stress in the pathogenesis of Alzheimer\u2019s disease and cerebrovascular disease with therapeutic implications","volume":"19","author":"Jurcau","year":"2020","journal-title":"CNS Neurol. Disord. -Drug Targets (Former. Curr. Drug Targets-CNS Neurol. Disord. )"},{"key":"10.1016\/j.arr.2024.102342_bib68","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnins.2018.00025","article-title":"Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer's disease","volume":"12","author":"Kametani","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2024.102342_bib69","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1471-4159.2011.07512.x","article-title":"Identification and biology of \u03b2-secretase","volume":"120","author":"Kandalepas","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2024.102342_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2023.2274975","article-title":"Structural and molecular insights into tacrine-benzofuran hybrid induced inhibition of amyloid-\u03b2 peptide aggregation and BACE1 activity","author":"Kaur","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.arr.2024.102342_bib71","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad9704","article-title":"The BACE1 inhibitor verubecestat (MK-8931) reduces CNS \u03b2-amyloid in animal models and in Alzheimer\u2019s disease patients","volume":"8","author":"Kennedy","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.arr.2024.102342_bib72","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1038\/s41598-023-32073-x","article-title":"Iron response elements (IREs)-mRNA of Alzheimer's amyloid precursor protein binding to iron regulatory protein (IRP1): a combined molecular docking and spectroscopic approach","volume":"13","author":"Khan","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102342_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101924","article-title":"Nature's Toolbox Against Tau Aggregation: An Updated Review of Current Research","author":"Khan","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102342_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102113","article-title":"Recent advancement in therapeutic strategies for Alzheimer\u2019s disease: Insights from clinical trials","author":"Khan","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.arr.2024.102342_bib75","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13024-018-0239-7","article-title":"BACE1 elevation engendered by GGA3 deletion increases \u03b2-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice","volume":"13","author":"Kim","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2024.102342_bib76","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bmcl.2004.09.090","article-title":"Design and synthesis of highly active Alzheimer\u2019s \u03b2-secretase (BACE1) inhibitors, KMI-420 and KMI-429, with enhanced chemical stability","volume":"15","author":"Kimura","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.arr.2024.102342_bib77","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.3390\/molecules22101723","article-title":"BACE1 function and inhibition: implications of intervention in the amyloid pathway of Alzheimer\u2019s disease pathology","volume":"22","author":"Koelsch","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2024.102342_bib78","doi-asserted-by":"crossref","first-page":"9689","DOI":"10.3390\/ijms22189689","article-title":"On the common journey of neural cells through ischemic brain injury and Alzheimer\u2019s disease","volume":"22","author":"Kriska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102342_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00894-021-04679-3","article-title":"Identification of new BACE1 inhibitors for treating Alzheimer\u2019s disease","volume":"27","author":"Kushwaha","year":"2021","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.arr.2024.102342_bib80","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jlcr.4022","article-title":"Synthesis of beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors BI 1147560 and BI 1181181 labeled with carbon-14 and deuterium.","volume":"66","author":"Latli","year":"2023","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.arr.2024.102342_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.813536","article-title":"Multifocal cerebral microinfarcts modulate early Alzheimer\u2019s disease pathology in a sex-dependent manner.","volume":"12","author":"Lecordier","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.arr.2024.102342_bib82","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3390\/molecules23071509","article-title":"In silico docking and in vitro approaches towards BACE1 and cholinesterases inhibitory effect of citrus flavanones","volume":"23","author":"Lee","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2024.102342_bib83","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/19336950.2016.1196307","article-title":"Ion channel regulation by \u03b2-secretase BACE1\u2013enzymatic and non-enzymatic effects beyond Alzheimer's disease","volume":"10","author":"Lehnert","year":"2016","journal-title":"Channels"},{"key":"10.1016\/j.arr.2024.102342_bib84","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3390\/antiox11040727","article-title":"Investigating a curcumin-Loaded PLGA-PEG-PLGA thermo-sensitive hydrogel for the prevention of Alzheimer\u2019s disease","volume":"11","author":"Lin","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.arr.2024.102342_bib85","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2024.102342_bib86","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41392-019-0063-8","article-title":"History and progress of hypotheses and clinical trials for Alzheimer\u2019s disease","volume":"4","author":"Liu","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.arr.2024.102342_bib87","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4252\/wjsc.v12.i8.787","article-title":"Stem cell therapy for Alzheimer's disease","volume":"12","author":"Liu","year":"2020","journal-title":"World J. stem Cells"},{"key":"10.1016\/j.arr.2024.102342_bib88","doi-asserted-by":"crossref","first-page":"772","DOI":"10.2174\/1567205018666211208141017","article-title":"The Alzheimer\u2019s disease amyloid precursor protein and its neuritogenic actions","volume":"18","author":"Luu","year":"2021","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.arr.2024.102342_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2018.07.213","article-title":"P4-389: elenbecestat, E2609, a bace inhibitor: results from a phase-2 study in subjects with mild cognitive impairment and mild-to-moderate dementia due to Alzheimer's disease.","volume":"14","author":"Lynch","year":"2018","journal-title":"Alzheimer'S. Dement."},{"key":"10.1016\/j.arr.2024.102342_bib90","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14613","article-title":"Targeting blood brain barrier\u2014Remote ischemic conditioning alleviates cognitive impairment in female APP\/PS1 rats.","volume":"30","author":"Ma","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.arr.2024.102342_bib91","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fnagi.2014.00165","article-title":"\u03b2-secretase inhibitor; a promising novel therapeutic drug in Alzheimer\u2019s disease","volume":"6","author":"Menting","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2024.102342_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-201027","article-title":"Selective secretase targeting for Alzheimer\u2019s disease therapy","volume":"81","author":"Miranda","year":"2021","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.arr.2024.102342_bib93","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/17425255.2021.1931681","article-title":"Does the application of acetylcholinesterase inhibitors in the treatment of Alzheimer\u2019s disease lead to depression?","volume":"17","author":"Miti\u0107","year":"2021","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.arr.2024.102342_bib94","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10571-020-00979-z","article-title":"Epigenetic changes and its intervention in age-related neurodegenerative diseases","volume":"42","author":"Mohd Murshid","year":"2022","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.arr.2024.102342_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103487","article-title":"Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies","volume":"28","author":"Moore","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.arr.2024.102342_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2017.06.1850","article-title":"[P3\u2013037]: Preclinical studies with elenbecestat, a novel bace1 inhibitor, show no evidence of hypopigmentation","volume":"13","author":"Moriyama","year":"2017","journal-title":"Alzheimer'S. Dement."},{"key":"10.1016\/j.arr.2024.102342_bib97","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/med.21622","article-title":"BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease","volume":"40","author":"Moussa-Pacha","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.arr.2024.102342_bib98","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ijbiomac.2020.07.327","article-title":"Role of tau protein in Alzheimer's disease: The prime pathological player","volume":"163","author":"Muralidar","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2024.102342_bib99","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00232-022-00225-1","article-title":"Finding New Ways How to Control BACE1","volume":"255","author":"Nah\u00e1lkov\u00e1","year":"2022","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.arr.2024.102342_bib100","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94369-0","article-title":"BACE inhibitor treatment of mice induces hyperactivity in a seizure-related gene 6 family dependent manner without altering learning and memory","volume":"11","author":"Nash","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2024.102342_bib101","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1055\/a-1019-9819","article-title":"Natural compounds with anti-BACE1 activity as promising therapeutic drugs for treating Alzheimer\u02bcs disease","volume":"85","author":"Naushad","year":"2019","journal-title":"Planta Med."},{"key":"10.1016\/j.arr.2024.102342_bib102","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809316","article-title":"The BACE-1 inhibitor CNP 520 for prevention trials in Alzheimer's disease","volume":"10","author":"Neumann","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.arr.2024.102342_bib103","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1111\/bph.14582","article-title":"The \u03b2-secretase (BACE) inhibitor NB-360 in preclinical models: From amyloid-\u03b2 reduction to downstream disease-relevant effects","volume":"176","author":"Neumann","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.arr.2024.102342_bib104","series-title":"Seminars in cell & developmental biology","first-page":"43","article-title":"\u03b3-Secretase inhibitors and modulators: Mechanistic insights into the function and regulation of \u03b3-Secretase","author":"Nie","year":"2020"},{"key":"10.1016\/j.arr.2024.102342_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101994","article-title":"Neurotransmitter systems in the etiology of major neurological disorders: Emerging insights and therapeutic implications","author":"Nimgampalle","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102342_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-020-00614-5","article-title":"Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer\u2019s disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension study","volume":"12","author":"Novak","year":"2020","journal-title":"Alzheimer'S. Res. Ther."},{"key":"10.1016\/j.arr.2024.102342_bib107","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","article-title":"Oxidative damage is the earliest event in Alzheimer disease","volume":"60","author":"Nunomura","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.arr.2024.102342_bib108","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0896-6273(03)00810-9","article-title":"BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease","volume":"41","author":"Ohno","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2024.102342_bib109","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1007\/s11064-023-04005-8","article-title":"The Effects and Mechanisms of Xanthones in Alzheimer\u2019s Disease: A Systematic Review","volume":"48","author":"Pang","year":"2023","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.arr.2024.102342_bib110","first-page":"1","article-title":"Alzheimer\u2019s disease-related epigenetic changes: novel therapeutic targets","author":"Paniri","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2024.102342_bib111","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41583-019-0257-7","article-title":"The future of stem cell therapies for Parkinson disease","volume":"21","author":"Parmar","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2024.102342_bib112","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.3390\/ijms24032302","article-title":"Knockdown of Amyloid Precursor Protein Increases Ion Channel Expression and Alters Ca2+ Signaling Pathways","volume":"24","author":"Paschou","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102342_bib113","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/mcne.2001.1065","article-title":"The carboxyl-terminus of BACE contains a sorting signal that regulates BACE trafficking but not the formation of total A\u03b2.","volume":"19","author":"Pastorino","year":"2002","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.arr.2024.102342_bib114","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2174\/1570159X19666211201094031","article-title":"BACE1: a key regulator in Alzheimer\u2019s disease progression and current development of its inhibitors","volume":"20","author":"Patel","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.arr.2024.102342_bib115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1212\/WNL.0b013e3181e7ca97","article-title":"Head circumference, atrophy, and cognition: implications for brain reserve in Alzheimer disease","volume":"75","author":"Perneczky","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2024.102342_bib116","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1021\/acsmedchemlett.1c00445","article-title":"A Brain-Penetrant and Bioavailable Pyrazolopiperazine BACE1 Inhibitor Elicits Sustained Reduction of Amyloid \u03b2 In Vivo","volume":"13","author":"Peschiulli","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.arr.2024.102342_bib117","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13024-016-0134-z","article-title":"Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons","volume":"11","author":"Pigoni","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2024.102342_bib118","doi-asserted-by":"crossref","first-page":"791","DOI":"10.4103\/1673-5374.322453","article-title":"Brain ischemia as a bridge to Alzheimer\u2019s disease","volume":"17","author":"Pluta","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.arr.2024.102342_bib119","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.636653","article-title":"Brain ischemia as a prelude to Alzheimer's disease","volume":"13","author":"Pluta","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2024.102342_bib120","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.3390\/ijms22094405","article-title":"Neuroinflammation in post-ischemic neurodegeneration of the brain: friend, foe, or both?","volume":"22","author":"Pluta","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2024.102342_bib121","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/156720508783954668","article-title":"A closer look at \u03b1-secretase","volume":"5","author":"Postina","year":"2008","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.arr.2024.102342_bib122","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1021\/acs.jmedchem.7b00393","article-title":"BACE-1 inhibitors: from recent single-target molecules to multitarget compounds for Alzheimer\u2019s disease: miniperspective","volume":"61","author":"Prati","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.arr.2024.102342_bib123","doi-asserted-by":"crossref","first-page":"19777","DOI":"10.1074\/jbc.M300466200","article-title":"Ceramide stabilizes \u03b2-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid \u03b2-peptide biogenesis","volume":"278","author":"Puglielli","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102342_bib124","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/med.21947","article-title":"Regulation of beta-amyloid for the treatment of Alzheimer's disease: Research progress of therapeutic strategies and bioactive compounds","volume":"43","author":"Qiu","year":"2023","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.arr.2024.102342_bib125","doi-asserted-by":"crossref","first-page":"23780","DOI":"10.1039\/C8RA03620A","article-title":"Current progress, challenges and future prospects of diagnostic and therapeutic interventions in Alzheimer's disease","volume":"8","author":"Rajasekhar","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.arr.2024.102342_bib126","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0197-4580(02)00230-0","article-title":"Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex","volume":"24","author":"Rees","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2024.102342_bib127","series-title":"Diagnosis and Management in Dementia","first-page":"617","article-title":"Changing fate: therapeutic mechanisms focused on the switch of amyloid precursor protein processing","author":"Reinhardt","year":"2020"},{"key":"10.1016\/j.arr.2024.102342_bib128","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","article-title":"Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers","volume":"88","author":"Reitz","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.arr.2024.102342_bib129","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrneurol.2011.2","article-title":"Epidemiology of Alzheimer disease","volume":"7","author":"Reitz","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2024.102342_bib130","doi-asserted-by":"crossref","DOI":"10.1002\/alz.062504","article-title":"A new BACE-1 inhibitor peptide from Macrorhynchia philippina.","volume":"19","author":"Renzo","year":"2023","journal-title":"Alzheimer'S. Dement."},{"key":"10.1016\/j.arr.2024.102342_bib131","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3233\/JAD-200381","article-title":"New BACE1 chimeric peptide inhibitors selectively prevent A\u03b2PP-\u03b2 cleavage decreasing amyloid-\u03b2 production and accumulation in Alzheimer\u2019s disease models","volume":"76","author":"Resende","year":"2020","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.arr.2024.102342_bib132","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3606765","article-title":"Advancements in the use of hydrogels for regenerative medicine: properties and biomedical applications","volume":"2022","author":"Revete","year":"2022","journal-title":"Int. J. Biomater."},{"key":"10.1016\/j.arr.2024.102342_bib133","doi-asserted-by":"crossref","first-page":"10658","DOI":"10.1073\/pnas.1220748110","article-title":"BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells","volume":"110","author":"Rochin","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2024.102342_bib134","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1096\/fj.201802315R","article-title":"The crystal structure of amyloid precursor-like protein 2 E2 domain completes the amyloid precursor protein family","volume":"33","author":"Roisman","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2024.102342_bib135","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1096\/fj.201902347R","article-title":"Mouse brain proteomics establishes MDGA1 and CACHD1 as in vivo substrates of the Alzheimer protease BACE1","volume":"34","author":"Rudan Njavro","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2024.102342_bib136","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ebiom.2017.09.004","article-title":"Potent and selective BACE-1 peptide inhibitors lower brain A\u03b2 levels mediated by brain shuttle transport","volume":"24","author":"Ruderisch","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.arr.2024.102342_bib137","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/jnc.13932","article-title":"Hypoxia\/ischemia activate processing of Amyloid Precursor Protein: impact of vascular dysfunction in the pathogenesis of Alzheimer's disease","volume":"140","author":"Salminen","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2024.102342_bib138","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.2174\/0929867323666161213101126","article-title":"Alzheimer's disease: a review from the pathophysiology to diagnosis, new perspectives for pharmacological treatment.","volume":"25","author":"dos Santos","year":"2018","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.arr.2024.102342_bib139","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13195-020-00635-0","article-title":"Partial reduction of amyloid \u03b2 production by \u03b2-secretase inhibitors does not decrease synaptic transmission","volume":"12","author":"Satir","year":"2020","journal-title":"Alzheimer'S. Res. Ther."},{"key":"10.1016\/j.arr.2024.102342_bib140","series-title":"Discovery of the 3-imino-1, 2, 4-thiadiazinane 1","article-title":"1-dioxide derivative verubecestat (MK-8931)\u2013a \u03b2-site amyloid precursor protein cleaving enzyme 1 inhibitor for the treatment of Alzheimer\u2019s disease","author":"Scott","year":"2016"},{"key":"10.1016\/j.arr.2024.102342_bib141","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.arr.2024.102342_bib142","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000094772","article-title":"Unraveling in vivo functions of amyloid precursor protein: insights from knockout and knockdown studies","volume":"3","author":"Senechal","year":"2006","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.arr.2024.102342_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104794","article-title":"Selective inhibitors of the PSEN1\u2013gamma-secretase complex","volume":"299","author":"Serneels","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102342_bib144","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.870517","article-title":"Impact of anti-amyloid-\u03b2 monoclonal antibodies on the pathology and clinical profile of Alzheimer\u2019s disease: a focus on aducanumab and lecanemab","volume":"14","author":"Shi","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2024.102342_bib145","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.02185-07","article-title":"Crystal structure of an active form of BACE1, an enzyme responsible for amyloid \u03b2 protein production","author":"Shimizu","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.arr.2024.102342_bib146","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12974-022-02565-0","article-title":"Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer\u2019s disease","volume":"19","author":"Singh","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.arr.2024.102342_bib147","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jamaneurol.2020.4857","article-title":"Findings of efficacy, safety, and biomarker outcomes of atabecestat in preclinical Alzheimer disease: a truncated randomized phase 2b\/3 clinical trial","volume":"78","author":"Sperling","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2024.102342_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101960","article-title":"Alzheimer's disease: molecular aspects and treatment opportunities using herbal drugs","author":"Thakral","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102342_bib149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","article-title":"Neuroinflammation in Alzheimer\u2019s disease: current progress in molecular signaling and therapeutics","volume":"46","author":"Thakur","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/j.arr.2024.102342_bib150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-018-0415-6","article-title":"Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer\u2019s disease: randomized, double-blind, placebo-controlled study","volume":"10","author":"Timmers","year":"2018","journal-title":"Alzheimer'S. Res. Ther."},{"key":"10.1016\/j.arr.2024.102342_bib151","author":"Triani","year":"2018","journal-title":"Impair. Insul. Signal. cascade Favors Dev. Alzheimer Dis. Pathol. Alter. Appl. Process. brain"},{"key":"10.1016\/j.arr.2024.102342_bib152","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/0929867328666210608145357","article-title":"An Overview of \u03b2-Amyloid Cleaving Enzyme 1 (BACE1) in Alzheimer's Disease Therapy: Elucidating its Exosite-Binding Antibody and Allosteric Inhibitor","volume":"29","author":"Ugbaja","year":"2022","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.arr.2024.102342_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101451","article-title":"Abnormal amyloid beta metabolism in systemic abnormalities and Alzheimer\u2019s pathology: Insights and therapeutic approaches from periphery","volume":"71","author":"Ullah","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102342_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102298","article-title":"Innovative Approaches to Alzheimer's Therapy: Harnessing the Power of Heterocycles, Oxidative Stress Management, and Nanomaterial Drug Delivery System","author":"Umar","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102342_bib155","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0169-409X(02)00157-6","article-title":"\u03b2-secretase (BACE) as a drug target for Alzheimer\u2019s disease","volume":"54","author":"Vassar","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.arr.2024.102342_bib156","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1385\/JMN:23:1-2:105","article-title":"Bace 1: The \u03b2-secretase enzyme in alzheimer\u2019s disease","volume":"23","author":"Vassar","year":"2004","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.arr.2024.102342_bib157","first-page":"78","article-title":"Implications for bace1 inhibitor clinical trials: Adult conditional bace1 knockout mice exhibit axonal organization defects in the hippocampus","author":"Vassar","year":"2019","journal-title":"Springer"},{"key":"10.1016\/j.arr.2024.102342_bib158","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2174\/138920207783769512","article-title":"The basic biology of BACE1: A key therapeutic target for Alzheimer's disease","volume":"8","author":"Vassar","year":"2007","journal-title":"Curr. Genom."},{"key":"10.1016\/j.arr.2024.102342_bib159","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jnc.12715","article-title":"Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects","volume":"130","author":"Vassar","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2024.102342_bib160","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1074\/jbc.M808920200","article-title":"Alzheimer disease A\u03b2 production in the absence of S-palmitoylation-dependent targeting of BACE1 to lipid rafts","volume":"284","author":"Vetrivel","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102342_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101988","article-title":"BACE1-dependent metabolism of neuregulin 1: Bridging the gap in explaining the occurrence of schizophrenia-like symptoms in Alzheimer's disease with psychosis?","author":"Vincent","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.arr.2024.102342_bib162","article-title":"Progression from Prodromal Alzheimer\u2019s Disease to Mild Alzheimer\u2019s Disease Dementia in the Verubecestat APECS Study: Adjudicating Diagnostic Transitions","volume":"8","author":"Voss","year":"2023","journal-title":"J. Alzheimer'S. Dis."},{"key":"10.1016\/j.arr.2024.102342_bib163","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201800026","article-title":"BACE2 distribution in major brain cell types and identification of novel substrates","volume":"1","author":"Voytyuk","year":"2018","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.arr.2024.102342_bib164","first-page":"1","article-title":"Delineation of neuroprotective effects and possible benefits of antioxidantstherapy for the treatment of Alzheimer\u2019s diseases by targeting mitochondrial-derived reactive oxygen species: bench to bedside.","author":"Walia","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2024.102342_bib165","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.tips.2013.01.008","article-title":"\u03b2-Secretase: its biology as a therapeutic target in diseases","volume":"34","author":"Wang","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.arr.2024.102342_bib166","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40035-020-00189-z","article-title":"Current understanding of metal ions in the pathogenesis of Alzheimer\u2019s disease","volume":"9","author":"Wang","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2024.102342_bib167","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.arr.2016.11.002","article-title":"Stem cell therapies in age-related neurodegenerative diseases and stroke","volume":"34","author":"Wang","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102342_bib168","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.2147\/NDT.S237406","article-title":"Lupeol alleviates cerebral ischemia\u2013reperfusion injury in correlation with modulation of PI3K\/Akt pathway","author":"Wang","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.arr.2024.102342_bib169","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-016-0174-1","article-title":"Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy","volume":"8","author":"Wattmo","year":"2016","journal-title":"Alzheimer'S. Res. Ther."},{"key":"10.1016\/j.arr.2024.102342_bib170","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2174\/1570159X19666210121163224","article-title":"Post-translational modifications of BACE1 in Alzheimer's disease","volume":"20","author":"Wen","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.arr.2024.102342_bib171","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jamaneurol.2019.3988","article-title":"Efficacy and safety of lanabecestat for treatment of early and mild Alzheimer disease: the AMARANTH and DAYBREAK-ALZ randomized clinical trials","volume":"77","author":"Wessels","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2024.102342_bib172","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fnmol.2017.00021","article-title":"Structure and synaptic function of metal binding to the amyloid precursor protein and its proteolytic fragments","volume":"10","author":"Wild","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.arr.2024.102342_bib173","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40035-016-0061-5","article-title":"Stepping closer to treating Alzheimer\u2019s disease patients with BACE1 inhibitor drugs","volume":"5","author":"Yan","year":"2016","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2024.102342_bib174","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1021\/jm301659n","article-title":"Structure-based design of \u03b2-site APP cleaving enzyme 1 (BACE1) inhibitors for the treatment of Alzheimer\u2019s disease","volume":"56","author":"Yuan","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.arr.2024.102342_bib175","article-title":"Immunotherapy targeting Amyloid-\u03b2 peptides in Alzheimer\u2019s disease","author":"Zampar","year":"2020","journal-title":"Alzheimer\u2019S. Dis.: Drug Discov."},{"key":"10.1016\/j.arr.2024.102342_bib176","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/med.21624","article-title":"Advance of sporadic Alzheimer's disease animal models","volume":"40","author":"Zhang","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.arr.2024.102342_bib177","article-title":"Degradation and inhibition of epigenetic regulatory protein BRD4 exacerbate Alzheimer\u2019s disease-related neuropathology in cell models","volume":"298","author":"Zhang","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2024.102342_bib178","first-page":"890","article-title":"Effect of electroacupuncture on proliferation and differentiation of endogenous neural stem cells and Jagged1\/Notch1 pathway in hippocampus of APP\/PS1 model mice.","volume":"48","author":"Zhang","year":"2023","journal-title":"Zhen ci yan jiu= Acupunct. Res."},{"key":"10.1016\/j.arr.2024.102342_bib179","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3389\/fnmol.2017.00302","article-title":"BACE1-dependent neuregulin-1 signaling: an implication for schizophrenia","volume":"10","author":"Zhang","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.arr.2024.102342_bib180","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jinorgbio.2018.10.005","article-title":"Nitration of amyloid-\u03b2 peptide (1\u201342) as a protective mechanism for the amyloid-\u03b2 peptide (1\u201342) against copper ion toxicity","volume":"190","author":"Zhao","year":"2019","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.arr.2024.102342_bib181","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fnmol.2020.00137","article-title":"Targeting amyloidogenic processing of APP in Alzheimer\u2019s disease","volume":"13","author":"Zhao","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.arr.2024.102342_bib182","doi-asserted-by":"crossref","first-page":"720","DOI":"10.2174\/1570159X18666200114163636","article-title":"Molecular mechanism of autophagy: Its role in the therapy of Alzheimer\u2019s disease","volume":"18","author":"Zhao","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.arr.2024.102342_bib183","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.biopsych.2016.12.023","article-title":"Beta-site amyloid precursor protein cleaving enzyme 1 inhibition impairs synaptic plasticity via seizure protein 6","volume":"83","author":"Zhu","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.arr.2024.102342_bib184","series-title":"The diseased brain and the failing mind: Dementia in science, medicine and literature of the long twentieth century","author":"Zimmermann","year":"2020"}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724001600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724001600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T04:59:16Z","timestamp":1731992356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163724001600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":184,"alternative-id":["S1568163724001600"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2024.102342","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Navigating the Maze of Alzheimer\u2019s disease by exploring BACE1: Discovery, current scenario, and future prospects","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2024.102342","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102342"}}